Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome

Sponsor
Istanbul University-Cerrahpasa (Other)
Overall Status
Recruiting
CT.gov ID
NCT05535543
Collaborator
(none)
60
1
9.8
6.1

Study Details

Study Description

Brief Summary

This study evaluates the effects of prone positioning on homogenization of ventilation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Prone Positioning

Detailed Description

After initiation of mechanical ventilation and assessing the eligibility of the patient, informed consent will be taken from the closest kin. If eligible, following steps will be performed which are part of standard ARDS patient care.

  1. Low-flow Pressure Volume curve and assessment of airway opening pressure

  2. Calculation of recruitment to inflation ratio

  3. Optimizing Positive End-Expiratory Pressure

Afterwards, phase III slope of the patient will be recorded at four timepoints:

Supine 1 (immediately before turning to prone position) Prone 1 (immediately after prone position) Prone 2 (at the end of the 16-24 hour prone cycle) Supine 2 (immediately after turning to supine position)

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment of the Effects of Prone Positioning Among ARDS Patients on Ventilation Homogenization by the Phase Iii Slope of the Volumetric Capnography
Actual Study Start Date :
Sep 6, 2022
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Baseline slope of phase iii

Severe ARDS patients who are intubated and mechanically ventilated and will undergo prone positioning

Procedure: Prone Positioning
Patients will be turned to prone position and they will be left in prone position for a duration of at least 16 hours to a maximum of 24 hours. This duration is recommended by the ARDS guidelines.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in phase iii slope of the volumetric capnograph [16 to 24 hours (according to time spent in the prone position)]

    phase iii slope is associated with the ventilation homogeneity

  2. correlation of the phase iii slope with the recruitment to inflation ratio [16 to 24 hours (according to time spent in the prone position)]

    recruitment to inflation ratio is a simple bedside tool that indicates a higher possible recruitable lung with higher applied Positive End-Expiratory Pressure

Secondary Outcome Measures

  1. correlation of the phase iii slope with the Partial pressure of the arterial oxygen/ Fraction of inspired O2 concentration (PaO2/FiO2) ratio [16 to 24 hours (according to time spent in the prone position)]

    PaO2/FiO2 is markedly reduced in ARDS patients as a consequence of aeration loss

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ARDS criteria met

  • intubated and mechanically ventilated as a result of respiratory failure

  • PaO2/FiO2 <200

Exclusion Criteria:
  • age older than 18

  • Chronic pulmonary disease, pneumothoraces, intraabdominal hypertension (> 12 mmHg), pregnancy, not expected to survive >24 hours, hemodynamic instability

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hamidiye Etfal Hospital Istanbul Turkey 34000

Sponsors and Collaborators

  • Istanbul University-Cerrahpasa

Investigators

  • Principal Investigator: Olcay Dilken, MD, Hamidiye Etfal Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Olcay Dilken, MD, Istanbul University-Cerrahpasa
ClinicalTrials.gov Identifier:
NCT05535543
Other Study ID Numbers:
  • 05072022-3605
First Posted:
Sep 10, 2022
Last Update Posted:
Sep 10, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Olcay Dilken, MD, Istanbul University-Cerrahpasa
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 10, 2022